Trial · NCT03335488
Results by group20
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 20
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Rate of Treatment Success (Percentage of Participants Defined as Treatment Success at Week 4) During the Initial Treatment Period | RAVICTI | 81.8 | percentage of participants | ||
| Rate of Treatment Success (Percentage of Participants Defined as Treatment Success at Week 4) During the Initial Treatment Period | NaPBA | 80.0 | percentage of participants | ||
| Rate of Drug Discontinuations (Percentage of Participants Who Discontinued Study Drug) Due to Any Reason in the Initial Treatment Period | RAVICTI | 0 | percentage of participants | ||
| Rate of Drug Discontinuations (Percentage of Participants Who Discontinued Study Drug) Due to Any Reason in the Initial Treatment Period | NaPBA | 0 | percentage of participants | ||
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | RAVICTI | Week 1 | 6.5 | Standard Deviation 21.16 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | NaPBA | Week 1 | 0.0 | Standard Deviation 10.12 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | RAVICTI | Week 2 | 25.5 | Standard Deviation 59.88 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | NaPBA | Week 2 | -10.4 | Standard Deviation 10.17 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | RAVICTI | Week 3 | 7.4 | Standard Deviation 35.91 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | NaPBA | Week 3 | -10.9 | Standard Deviation 6.40 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | RAVICTI | Week 4: 0 hour | 2.1 | Standard Deviation 15.52 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | NaPBA | Week 4: 0 hour | -0.3 | Standard Deviation 8.49 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | RAVICTI | Week 4: 4 hours postdose | 2.6 | Standard Deviation 23.49 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | NaPBA | Week 4: 4 hours postdose | -1.1 | Standard Deviation 8.68 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | RAVICTI | Week 4: 8 hours postdose | 23.4 | Standard Deviation 62.09 | µmol/L |
| Change From Baseline in Fasting Plasma Ammonia Levels During the Initial Treatment Period | NaPBA | Week 4: 8 hours postdose | -0.7 | Standard Deviation 7.37 | µmol/L |
| Plasma Ammonia Area Under the Curve (AUC) 0 to 8h at the End of the Initial Treatment Period | RAVICTI | 331.8 | Standard Deviation 342.79 | µmol*h /L | |
| Plasma Ammonia Area Under the Curve (AUC) 0 to 8h at the End of the Initial Treatment Period | NaPBA | 258.9 | Standard Deviation 153.35 | µmol*h /L | |
| Peak Plasma Concentration (Cmax) of Ammonia at the End of the Initial Treatment Period | RAVICTI | 60.2 | Standard Deviation 78.47 | µmol/L | |
| Peak Plasma Concentration (Cmax) of Ammonia at the End of the Initial Treatment Period | NaPBA | 38.1 | Standard Deviation 18.91 | µmol/L |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03335488/results